Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

Also called NCT05366452

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05366452
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05366452. Randomized; no masking; primary purpose other. Start 2022-12-19 (actual); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
Acronym
ULYSS
Condition
Cardiogenic Shock
Intervention (Device)
IMPELLA CP
Intervention (Other)
Conventional therapy
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct05366452
Content hash
e67f8364b3f3e472ecac1ddba06ca04dd15b51800563df6c16fb98187c3db041